We are live on
!
Find out more
KC
Kades & Cheifetz Portfolio holdings
AUM
$195M
1-Year Est. Return
11.87%
This Fund
S&P 500
This Quarter
Est. Return
+4.41%
1 Year Est. Return
+11.87%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$127M
AUM Growth
+$7.21M
(+6%)
Cap. Flow
+$2.76M
Cap. Flow
% of AUM
2.18%
Top 10 Holdings %
Top 10 Hldgs %
52.25%
Holding
78
New
4
Increased
39
Reduced
21
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab 1-5 Year Corporate Bond ETF
SCHJ
|
+$643K |
| 2 |
Vanguard Dividend Appreciation ETF
VIG
|
+$478K |
| 3 |
Schwab Emerging Markets Equity ETF
SCHE
|
+$436K |
| 4 |
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
|
+$300K |
| 5 |
Invesco BulletShares 2028 Corporate Bond ETF
BSCS
|
+$259K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$626K |
| 2 |
IBML
iShares iBonds Dec 2023 Term Muni Bond ETF
IBML
|
+$353K |
| 3 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$213K |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
+$148K |
| 5 |
IBMN
iShares iBonds Dec 2025 Term Muni Bond ETF
IBMN
|
+$82.1K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.29% |
| 2 | Industrials | 1.53% |
| 3 | Communication Services | 1.28% |
| 4 | Healthcare | 1.18% |
| 5 | Consumer Staples | 0.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Arbutus Biopharma
ABUS
$847M
| $60.6K | 0.05% |
20,000
| – | – |
|
|
77
CVS Health
CVS
$134B
| – | – |
-6,720
| Closed | -$626K |
|
|
IBML
78
DELISTED
iShares iBonds Dec 2023 Term Muni Bond ETF
IBML
| – | – |
-13,925
| Closed | -$353K |
|
Similar funds
SL
QS
HPFG
LHR
CM
AJ
KWM
HFS
Kades & Cheifetz's Q1 2023 Portfolio in Review
As of Q1 2023, Kades & Cheifetz held 78 positions worth $127M, up 6% from $120M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Kades & Cheifetz's Q1 2023 filing shows 4 new, 39 increased, 21 reduced and 2 closed positions. Its largest new stake was Invesco BulletShares 2028 Corporate Bond ETF: 13,020 shares worth $261K. The largest sale was CVS Health, an estimated $626K.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 6.9% a quarter earlier, followed by Industrials and Communication Services.
- Kades & Cheifetz's largest Q1 2023 buy was Invesco BulletShares 2028 Corporate Bond ETF: 13,020 shares worth $261K.
- Kades & Cheifetz added most to Schwab 1-5 Year Corporate Bond ETF in Q1 2023, an estimated $643K increase.
- Kades & Cheifetz's biggest Q1 2023 reduction was Schwab US Aggregate Bond ETF, cutting an estimated $213K.
- Kades & Cheifetz fully exited CVS Health in Q1 2023, selling an estimated $626K.
- Kades & Cheifetz's ten largest holdings make up 52% of its $127M portfolio in Q1 2023.
- Kades & Cheifetz opened 4 new positions and closed 2 in Q1 2023.
- Kades & Cheifetz's portfolio value rose 6% quarter-over-quarter to $127M.
Based on Kades & Cheifetz's 13F filing for Q1 2023, filed 8 May 2023.